Request Deal Involvement

Bora Pharmaceuticals completed the acquisition of Upsher-Smith Laboratories from Sawai Group and Sumitomo for $210m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Katten Muchin Rosenman

legal advisors

Katten Muchin Rosenman

Stifel

financial advisors

Stifel

Debevoise & Plimpton

legal advisors

Debevoise & Plimpton

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

or

Principals

SAWAI GROUP HOLDINGS

bidder

SAWAI GROUP HOLDINGS

UPSHER-SMITH LABORATORIES INC

target

UPSHER-SMITH LABORATORIES INC

BORA PHARMACEUTICALS CO

vendor

BORA PHARMACEUTICALS CO

SUMITOMO CORPORATION OF AMERICAS

bidder

SUMITOMO CORPORATION OF AMERICAS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Bora Pharmaceuticals completed the acquisition of Upsher-Smith Laboratories from Sawai Group and Sumitomo for $210m.